SP16 Inflammatory Response Inhibition Trial
Clinical trial NCT04225533 · COMPLETED
Trial details
- NCT number
- NCT04225533
- Sponsor
- Serpin Pharma, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2021-01-04
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.